Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Crinetics Pharmaceuticals logo — Driving the next generation of endocrinology care. #acromeg...

Crinetics Pharmaceuticals

Driving the next generation of endocrinology care. #acromegaly #crinetics #CarcinoidSyndrome

Founded 2008 United States San Diego, United States 612 employees IPO Total: $1.48B Biotechnology, Health Care +2

General Information

Company Name Crinetics Pharmaceuticals
Founded Year 2008
Location United States San Diego, United States
Founders / Decision Makers
Team member Team member Team member
Employees 612
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage IPO
Social

BounceWatch is an independent company data service, not affiliated with Crinetics Pharmaceuticals. To contact Crinetics Pharmaceuticals, visit crinetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Crinetics Pharmaceuticals compare?

A PDF of Crinetics Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Crinetics Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Crinetics Pharmaceuticals

Crinetics Pharmaceuticals is a biotechnology startup based in the United States that focuses on discovering drugs for endocrine diseases and endocrine-related tumors. The company was founded in 2008 and has garnered significant attention in the industry, attracting a $350.00M post-IPO equity investment from a consortium of notable investors including Invus, Adage Capital Management, Driehaus Capital Management, EcoR1 Capital, First Light Asset Management, GordonMD Global Investments, Janus Handerson, Perceptive Advisors, Rock Springs Capital, and Paradigm BioCapital Advisors as of 28 February 2024. The company's mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Crinetics Pharmaceuticals is driven by its vision to provide the best possible therapeutics available to all patients with diseases of the endocrine system. The startup's dedication to making a real difference in the lives of patients sets it apart in the health care and pharmaceutical industries. With its focus on addressing unmet medical needs, Crinetics Pharmaceuticals stands out as a promising venture with a strong commitment to innovation and patient care.

Business keywords: Pharmaceuticals, Endocrine diseases, Drug discovery, Therapeutics, Patient care, Medical research, Acromegaly, Carcinoid syndrome, Endocrine tumors, Healthcare innovation

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $350.00M -
01 Jan 2026
Post-IPO Equity $575.00M -
01 Oct 2024
Private Placement VC $350.00M 10
Invus Adage Capital Management Driehaus Capital Management
Invus, Adage Capital Management +8
01 Feb 2024
Grant $102.00M -
01 Jul 2018
Series B $63.50M 6
RA Capital Management 5AM Ventures OrbiMed
RA Capital Management, 5AM Ventures +4
01 Mar 2018
Series A $40.00M 3
5AM Ventures Versant Ventures Vivo Capital
5AM Ventures, Versant Ventures +1
01 Nov 2015
Grant $1.50M -
01 Jan 2015
Grant Undisclosed 1
National Eye Institute (NEI)
National Eye Institute (NEI)
01 Apr 2014
Grant $2.20M 1
National Institute of Health
National Institute of Health
01 Sep 2013
Grant Undisclosed 1
National Institute of Health
National Institute of Health
01 Feb 2009

Crinetics Pharmaceuticals Alternatives & Competitors

View All Alternatives
Crinetics Pharmaceuticals vs
Dualyx
Dualyx Belgium

Discovery and development of highly innovative biologicals for the treatment of autoimmune and rare...

Series A
6 employees
Biotechnology, Health Care
Compare Crinetics Pharmaceuticals vs Dualyx
Crinetics Pharmaceuticals vs
ProGeLife
ProGeLife

Innovative research solutions for rare diseases

Non Equity Assistance
9 employees
Health Care, Health and Wellness
Compare Crinetics Pharmaceuticals vs ProGeLife
Crinetics Pharmaceuticals vs
ImmunAbs Inc.
ImmunAbs Inc.

ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope for Patient...

Series B
11 employees
Biotechnology, Health Care
Also compare with: Crinetics Pharmaceuticals vs Acadia Pharmaceuticals Acadia Pharmaceuticals Crinetics Pharmaceuticals vs Dewpoint Therapeutics Dewpoint Therapeutics View all alternatives

FAQ About Crinetics Pharmaceuticals

Driving the next generation of endocrinology care. #acromegaly #crinetics #CarcinoidSyndrome
Crinetics Pharmaceuticals was founded in 2008.
Crinetics Pharmaceuticals is headquartered in San Diego, United States.
Crinetics Pharmaceuticals operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Pharmaceuticals, Endocrine diseases, Drug discovery and Therapeutics.
Crinetics Pharmaceuticals has approximately 612 employees.
Crinetics Pharmaceuticals has completed 10 funding rounds, raising a total of $1.48B. The latest funding stage is IPO.
Top alternatives and competitors to Crinetics Pharmaceuticals include Dualyx, ProGeLife, ImmunAbs Inc., MILLENDO THERAPEUTICS, iN Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Crinetics Pharmaceuticals and Dualyx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Crinetics Pharmaceuticals, https://bouncewatch.com/company/crinetics-pharmaceuticals, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout